Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Phase 1 First-in-Human Study of Single Ascending Doses of ABS-101 to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Healthy Adult Participants

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 20 May 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

20 May 2025 New source identified and integrated (Australian New Zealand Clinical Trials Registry:ACTRN12625000212459p).
13 May 2025 According to Absci media release, company announced that the first healthy volunteers have been dosed in a randomized, placebo-controlled Phase 1 study evaluating ABS-101.
13 May 2025 Status changed from not yet recruiting to recruiting.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com